Name | Number of supported studies | Average coverage | |
---|---|---|---|
hepatocyte | 4 studies | 67% ± 14% |
Insufficient scRNA-seq data for expression of SLC22A1 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
liver | 100% | 31177.38 | 226 / 226 | 90% | 211.63 | 364 / 406 |
prostate | 98% | 51.96 | 240 / 245 | 31% | 0.47 | 154 / 502 |
thymus | 100% | 85.24 | 653 / 653 | 28% | 0.41 | 170 / 605 |
esophagus | 92% | 24.46 | 1327 / 1445 | 36% | 1.10 | 66 / 183 |
uterus | 99% | 38.98 | 169 / 170 | 26% | 1.15 | 118 / 459 |
kidney | 100% | 62.88 | 89 / 89 | 22% | 0.48 | 197 / 901 |
lung | 98% | 53.00 | 568 / 578 | 15% | 0.52 | 171 / 1155 |
bladder | 95% | 24.05 | 20 / 21 | 17% | 0.65 | 88 / 504 |
adrenal gland | 99% | 34.21 | 255 / 258 | 8% | 0.14 | 19 / 230 |
pancreas | 94% | 24.84 | 309 / 328 | 12% | 0.54 | 21 / 178 |
stomach | 94% | 26.10 | 339 / 359 | 11% | 0.42 | 32 / 286 |
ovary | 99% | 41.84 | 179 / 180 | 6% | 0.09 | 26 / 430 |
breast | 99% | 45.66 | 453 / 459 | 7% | 0.15 | 74 / 1118 |
intestine | 96% | 30.77 | 923 / 966 | 9% | 0.65 | 47 / 527 |
skin | 88% | 37.08 | 1587 / 1809 | 15% | 1.29 | 73 / 472 |
spleen | 100% | 179.65 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 1.49 | 1 / 1 |
muscle | 98% | 50.01 | 790 / 803 | 0% | 0 | 0 / 0 |
adipose | 98% | 41.52 | 1179 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 98% | 36.80 | 1306 / 1335 | 0% | 0 | 0 / 0 |
peripheral blood | 97% | 258.67 | 905 / 929 | 0% | 0 | 0 / 0 |
brain | 68% | 11.95 | 1806 / 2642 | 4% | 0.07 | 26 / 705 |
heart | 50% | 8.59 | 430 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 26% | 0.50 | 21 / 80 |
tonsil | 0% | 0 | 0 / 0 | 18% | 0.48 | 8 / 45 |
lymph node | 0% | 0 | 0 / 0 | 17% | 0.32 | 5 / 29 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0015844 | Biological process | monoamine transport |
GO_1902616 | Biological process | acyl carnitine transmembrane transport |
GO_0015695 | Biological process | organic cation transport |
GO_0006805 | Biological process | xenobiotic metabolic process |
GO_0015697 | Biological process | quaternary ammonium group transport |
GO_0015888 | Biological process | thiamine transport |
GO_0015847 | Biological process | putrescine transport |
GO_0150104 | Biological process | transport across blood-brain barrier |
GO_1902270 | Biological process | (R)-carnitine transmembrane transport |
GO_1990962 | Biological process | xenobiotic transport across blood-brain barrier |
GO_0090494 | Biological process | dopamine uptake |
GO_1903711 | Biological process | spermidine transmembrane transport |
GO_1990748 | Biological process | cellular detoxification |
GO_0072237 | Biological process | metanephric proximal tubule development |
GO_0071934 | Biological process | thiamine transmembrane transport |
GO_0048241 | Biological process | epinephrine transport |
GO_0015872 | Biological process | dopamine transport |
GO_0042908 | Biological process | xenobiotic transport |
GO_0051620 | Biological process | norepinephrine uptake |
GO_0015732 | Biological process | prostaglandin transport |
GO_0006837 | Biological process | serotonin transport |
GO_0098655 | Biological process | monoatomic cation transmembrane transport |
GO_0010248 | Biological process | establishment or maintenance of transmembrane electrochemical gradient |
GO_0015870 | Biological process | acetylcholine transport |
GO_0006836 | Biological process | neurotransmitter transport |
GO_0015874 | Biological process | norepinephrine transport |
GO_0051610 | Biological process | serotonin uptake |
GO_0072530 | Biological process | purine-containing compound transmembrane transport |
GO_0015848 | Biological process | spermidine transport |
GO_0016324 | Cellular component | apical plasma membrane |
GO_0098793 | Cellular component | presynapse |
GO_0005886 | Cellular component | plasma membrane |
GO_0016020 | Cellular component | membrane |
GO_0009925 | Cellular component | basal plasma membrane |
GO_0016328 | Cellular component | lateral plasma membrane |
GO_0016323 | Cellular component | basolateral plasma membrane |
GO_0015214 | Molecular function | pyrimidine nucleoside transmembrane transporter activity |
GO_0008514 | Molecular function | organic anion transmembrane transporter activity |
GO_0015489 | Molecular function | putrescine transmembrane transporter activity |
GO_0015101 | Molecular function | organic cation transmembrane transporter activity |
GO_0015651 | Molecular function | quaternary ammonium group transmembrane transporter activity |
GO_0005326 | Molecular function | neurotransmitter transmembrane transporter activity |
GO_0008513 | Molecular function | secondary active organic cation transmembrane transporter activity |
GO_0042802 | Molecular function | identical protein binding |
GO_0005334 | Molecular function | norepinephrine:sodium symporter activity |
GO_0008504 | Molecular function | monoamine transmembrane transporter activity |
GO_0015606 | Molecular function | spermidine transmembrane transporter activity |
GO_0019534 | Molecular function | toxin transmembrane transporter activity |
GO_0042910 | Molecular function | xenobiotic transmembrane transporter activity |
GO_0005277 | Molecular function | acetylcholine transmembrane transporter activity |
GO_0005330 | Molecular function | dopamine:sodium symporter activity |
GO_1901235 | Molecular function | (R)-carnitine transmembrane transporter activity |
GO_0015132 | Molecular function | prostaglandin transmembrane transporter activity |
GO_0015234 | Molecular function | thiamine transmembrane transporter activity |
GO_0005515 | Molecular function | protein binding |
Gene name | SLC22A1 |
Protein name | Solute carrier family 22 member 1 (Organic cation transporter 1) (hOCT1) Solute carrier family 22 member 1 |
Synonyms | OCT1 |
Description | FUNCTION: Electrogenic voltage-dependent transporter that mediates the transport of a variety of organic cations such as endogenous bioactive amines, cationic drugs and xenobiotics . Functions as a pH- and Na(+)-independent, bidirectional transporter (By similarity). Cation cellular uptake or release is driven by the electrochemical potential (i.e. membrane potential and concentration gradient) and substrate selectivity (By similarity). Hydrophobicity is a major requirement for recognition in polyvalent substrates and inhibitors (By similarity). Primarily expressed at the basolateral membrane of hepatocytes and proximal tubules and involved in the uptake and disposition of cationic compounds by hepatic and renal clearance from the blood flow (By similarity). Most likely functions as an uptake carrier in enterocytes contributing to the intestinal elimination of organic cations from the systemic circulation . Transports endogenous monoamines such as N-1-methylnicotinamide (NMN), guanidine, histamine, neurotransmitters dopamine, serotonin and adrenaline . Also transports natural polyamines such as spermidine, agmatine and putrescine at low affinity, but relatively high turnover . Involved in the hepatic uptake of vitamin B1/thiamine, hence regulating hepatic lipid and energy metabolism . Mediates the bidirectional transport of acetylcholine (ACh) at the apical membrane of ciliated cell in airway epithelium, thereby playing a role in luminal release of ACh from bronchial epithelium . Transports dopaminergic neuromodulators cyclo(his-pro) and salsolinol with lower efficency . Also capable of transporting non-amine endogenous compounds such as prostaglandin E2 (PGE2) and prostaglandin F2-alpha (PGF2-alpha) . May contribute to the transport of cationic compounds in testes across the blood-testis-barrier (Probable). Also involved in the uptake of xenobiotics tributylmethylammonium (TBuMA), quinidine, N-methyl-quinine (NMQ), N-methyl-quinidine (NMQD) N-(4,4-azo-n-pentyl)-quinuclidine (APQ), azidoprocainamide methoiodide (AMP), N-(4,4-azo-n-pentyl)-21-deoxyajmalinium (APDA) and 4-(4-(dimethylamino)styryl)-N-methylpyridinium (ASP) . .; FUNCTION: [Isoform 1]: Mediates the uptake of 1-methyl-4-phenylpyridinium (MPP(+)). .; FUNCTION: [Isoform 2]: Not able to uptake 1-methyl-4-phenylpyridinium (MPP(+)). .; FUNCTION: [Isoform 3]: Not able to uptake 1-methyl-4-phenylpyridinium (MPP(+)). .; FUNCTION: [Isoform 4]: Not able to uptake 1-methyl-4-phenylpyridinium (MPP(+)). . |
Accessions | ENST00000366963.9 [O15245-1] ENST00000457470.6 [O15245-3] ENST00000539263.5 ENST00000460902.2 [O15245-4] F5GY86 ENST00000324965.8 [O15245-2] ENST00000540443.1 F5H5P3 O15245 |